venBio Select Advisor »

Macrogenics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $91M 6.2M 14.72
2018-03-31 $79k 15k 5.44
2017-12-31 $39k 15k 2.72

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common (ALPN)

View all positions for venBio Select Advisor

Top funds holding Macrogenics

Bellevue Group
venBio Select Advisor
BlackRock
State Street Corporation
Vanguard Group
T. Rowe Price Investment Management
Frazier Life Sciences Management
T. Rowe Price Associates
Armistice Capital
RA Capital Management
Geode Capital Management
Rock Springs Capital Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Daniel D. Thurber

View all funds holding Macrogenics